Pharmacological Approaches in an Experimental Model of Non-Small Cell Lung Cancer: Effects on Tumor Biology

E-ISSN： 1873-4286|22|34|5300-5310

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.34, 2016-09, pp. : 5300-5310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhalation Delivery and Anti-tumor Activity of Celecoxib in Human Orthotopic Non-Small Cell Lung Cancer Xenograft Model

By Fulzele Suniket Chatterjee Abhijit Shaik Madhu Jackson Tanise Singh Mandip

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 2094-2106

Springer Publishing Company

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)

Current Drug Targets, Vol. 11, Iss. 1, 2010-01 ,pp. : 12-28

Bentham Science Publishers

Access to resources Recommend Favorite

Pemetrexed for the treatment of non-small cell lung cancer

By Genova Carlo

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 11, 2013-08 ,pp. : 1545-1558

Informa Healthcare

Access to resources Recommend Favorite

Economics of Treatments for Non-Small Cell Lung Cancer

By Chouaid Christos Atsou Kukovi

PharmacoEconomics, Vol. 27, Iss. 2, 2009-01 ,pp. : 113-125

Adis International

Access to resources Recommend Favorite